Lojewski Xenia, Srimasorn Sumitra, Rauh Juliane, Francke Silvan, Wobus Manja, Taylor Verdon, Araúzo-Bravo Marcos J, Hallmeyer-Elgner Susanne, Kirsch Matthias, Schwarz Sigrid, Schwarz Johannes, Storch Alexander, Hermann Andreas
Division of Neurodegenerative Diseases, Department of Neurology, University Center for Orthopaedics and Trauma Surgery and Center for Translational Bone, Joint and Soft Tissue Research, Department of Medicine I, Faculty of Medicine, and Department of Neurosurgery, Technische Universität Dresden, Dresden, Germany; Department of Biomedicine, University of Basel, Basel, Switzerland; Group of Computational Biology and Systems Biomedicine, Biodonostia Health Research Institute, San Sebastián, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain; Department for Translational Neurodegeneration, Technical University of Munich, German Centre for Neurodegenerative Diseases, Munich, Germany; Geriatric Hospital Haag, Haag, Germany; Department of Neurology, Technical University of Munich, Munich, Germany; Center for Regenerative Therapies Dresden, Dresden, Germany; German Center for Neurodegenerative Diseases Dresden, Dresden, Germany.
Division of Neurodegenerative Diseases, Department of Neurology, University Center for Orthopaedics and Trauma Surgery and Center for Translational Bone, Joint and Soft Tissue Research, Department of Medicine I, Faculty of Medicine, and Department of Neurosurgery, Technische Universität Dresden, Dresden, Germany; Department of Biomedicine, University of Basel, Basel, Switzerland; Group of Computational Biology and Systems Biomedicine, Biodonostia Health Research Institute, San Sebastián, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain; Department for Translational Neurodegeneration, Technical University of Munich, German Centre for Neurodegenerative Diseases, Munich, Germany; Geriatric Hospital Haag, Haag, Germany; Department of Neurology, Technical University of Munich, Munich, Germany; Center for Regenerative Therapies Dresden, Dresden, Germany; German Center for Neurodegenerative Diseases Dresden, Dresden, Germany
Stem Cells Transl Med. 2015 Oct;4(10):1223-33. doi: 10.5966/sctm.2015-0057. Epub 2015 Aug 24.
Brain perivascular cells have recently been identified as a novel mesodermal cell type in the human brain. These cells reside in the perivascular niche and were shown to have mesodermal and, to a lesser extent, tissue-specific differentiation potential. Mesenchymal stem cells (MSCs) are widely proposed for use in cell therapy in many neurological disorders; therefore, it is of importance to better understand the "intrinsic" MSC population of the human brain. We systematically characterized adult human brain-derived pericytes during in vitro expansion and differentiation and compared these cells with fetal and adult human brain-derived neural stem cells (NSCs) and adult human bone marrow-derived MSCs. We found that adult human brain pericytes, which can be isolated from the hippocampus and from subcortical white matter, are-in contrast to adult human NSCs-easily expandable in monolayer cultures and show many similarities to human bone marrow-derived MSCs both regarding both surface marker expression and after whole transcriptome profile. Human brain pericytes showed a negligible propensity for neuroectodermal differentiation under various differentiation conditions but efficiently generated mesodermal progeny. Consequently, human brain pericytes resemble bone marrow-derived MSCs and might be very interesting for possible autologous and endogenous stem cell-based treatment strategies and cell therapeutic approaches for treating neurological diseases.
Perivascular mesenchymal stem cells (MSCs) recently gained significant interest because of their appearance in many tissues including the human brain. MSCs were often reported as being beneficial after transplantation in the central nervous system in different neurological diseases; therefore, adult brain perivascular cells derived from human neural tissue were systematically characterized concerning neural stem cell and MSC marker expression, transcriptomics, and mesodermal and inherent neuroectodermal differentiation potential in vitro and in vivo after in utero transplantation. This study showed the lack of an innate neuronal but high mesodermal differentiation potential. Because of their relationship to mesenchymal stem cells, these adult brain perivascular mesodermal cells are of great interest for possible autologous therapeutic use.
脑周血管细胞最近被鉴定为人类大脑中一种新型的中胚层细胞类型。这些细胞存在于血管周围微环境中,并且已显示出具有中胚层以及在较小程度上的组织特异性分化潜能。间充质干细胞(MSC)被广泛提议用于许多神经系统疾病的细胞治疗;因此,更好地了解人类大脑的“内在”MSC群体非常重要。我们系统地表征了体外扩增和分化过程中成人来源的人脑周细胞,并将这些细胞与胎儿和成人来源的人脑神经干细胞(NSC)以及成人骨髓来源的MSC进行了比较。我们发现,与成人NSC不同,成人来源的人脑周细胞可以从海马体和皮质下白质中分离出来,在单层培养中易于扩增,并且在表面标志物表达和全转录组图谱方面都与人类骨髓来源的MSC有许多相似之处。在各种分化条件下,人脑周细胞向神经外胚层分化的倾向可忽略不计,但能有效地产生中胚层后代。因此,人脑周细胞类似于骨髓来源的MSC,对于基于自体和内源性干细胞的治疗策略以及治疗神经系统疾病的细胞治疗方法可能非常有意义。
血管周围间充质干细胞(MSC)最近因其在包括人类大脑在内的许多组织中的出现而备受关注。在不同的神经系统疾病中,MSC在移植到中枢神经系统后通常被报道具有益处;因此,对源自人类神经组织的成人脑周血管细胞在神经干细胞和MSC标志物表达、转录组学以及子宫内移植后体内外的中胚层和固有神经外胚层分化潜能方面进行了系统表征。这项研究表明其缺乏先天性神经元分化能力,但具有高的中胚层分化潜能。由于它们与间充质干细胞的关系,这些成人脑周血管中胚层细胞对于可能的自体治疗用途非常有意义。